| ADMA | asymmetric dimethylarginine |
| AGEs | advanced glycation end products |
| AMPK | AMP-activated protein kinase |
| ATF6 | activating transcription factor 6 |
| BH4 | tetrahydrobiopterin |
| CAD | coronary artery disease |
| CANTOS | Canakinumab Anti-inflammatory Thrombosis Outcomes Study |
| CCSs | chronic coronary syndromes |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (p16^INK4a) |
| CFR | coronary flow reserve |
| cGAS | cyclic GMP–AMP synthase |
| CKD | chronic kidney disease |
| CMD | coronary microvascular dysfunction |
| DAMPs | damage-associated molecular patterns |
| DM | diabetes mellitus |
| DRP1 | dynamin-related protein 1 |
| EAT | epicardial adipose tissue |
| eGFR | estimated glomerular filtration rate |
| eNOS | endothelial nitric oxide synthase |
| ER | endoplasmic reticulum |
| EVs | extracellular vesicles |
| FAK | focal adhesion kinase |
| GPX4 | glutathione peroxidase 4 |
| HIF-1α | hypoxia-inducible factor-1α |
| IL | interleukin |
| IMR | index of microcirculatory resistance |
| INOCA | ischemia with non-obstructive coronary arteries |
| IRE1α | inositol-requiring enzyme-1α |
| KLF2/4 | Krüppel-like factor 2/4 |
| MAPK | mitogen-activated protein kinase |
| MFR | myocardial flow reserve (PET-derived term corresponding to CFR) |
| MISEV2023 | Minimal Information for Studies of Extracellular Vesicles 2023 |
| mTOR | mechanistic target of rapamycin |
| mTORC1 | mechanistic target of rapamycin complex 1 |
| mtDNA | mitochondrial DNA |
| NAD+ | nicotinamide adenine dinucleotide |
| NETs | neutrophil extracellular traps |
| NF-κB | nuclear factor kappa B |
| NO | nitric oxide |
| NOX | NADPH oxidase |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| OXPHOS | oxidative phosphorylation |
| PARs | protease-activated receptors |
| PERK | protein kinase R-like endoplasmic reticulum kinase |
| PET | positron emission tomography |
| PI3K–Akt | phosphoinositide 3-kinase–Akt signaling pathway |
| PKC | protein kinase C |
| PVAT | perivascular adipose tissue |
| RAGE | receptor for advanced glycation end products |
| RIPK | receptor-interacting protein kinase |
| ROS | reactive oxygen species |
| RRR | resistance reserve ratio |
| SASP | senescence-associated secretory phenotype |
| SGLT2 | sodium–glucose cotransporter 2 |
| SLE | systemic lupus erythematosus |
| STAT3 | signal transducer and activator of transcription 3 |
| STING | stimulator of interferon genes |
| TCA | tricarboxylic acid cycle |
| TNF-α | tumor necrosis factor-α |
| UPR | unfolded protein response |